Legacy devices also require performance evaluation plans, but their approach differs from new in vitro diagnostic medical devices. Manufacturers must re-examine their previous clinical evidence to assess its suitability under the IVDR. If the previous clinical data does not meet the IVDR requirements, manufacturers should evaluate how any gaps can be filled in the performance evaluation plan.